1. Anti-inflammatory and cartilage-protecting effects of an intra-articularly injected anti-TNFα single-chain Fv antibody (ESBA105) designed for local therapeutic use. Issue 2 (16th March 2009) Authors: Urech, D M; Feige, U; Ewert, S; Schlosser, V; Ottiger, M; Polzer, K; Schett, G; Lichtlen, P Journal: Annals of the rheumatic diseases Issue: Volume 69:Issue 2(2010) Page Start: 443 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Anti-interleukin 17A therapy inhibits tumour necrosis factor-mediated bone loss by modulation of T cell balance. (9th March 2010) Authors: Polzer, K; Koenders, M; Baum, W; Patakas, A; Mcinnes, I; Joosten, L; Schett, G; van den Berg, W; Zwerina, J Journal: Annals of the rheumatic diseases Issue: Volume 69(2010)Supplement 2 Page Start: A18 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. CTLA-4 directly inhibits osteoclast formation. Issue 11 (18th January 2008) Authors: Axmann, R; Herman, S; Zaiss, M; Franz, S; Polzer, K; Zwerina, J; Herrmann, M; Smolen, J; Schett, G Journal: Annals of the rheumatic diseases Issue: Volume 67:Issue 11(2008) Page Start: 1603 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Interleukin-1 is essential for systemic inflammatory bone loss. Issue 01 (5th February 2009) Authors: Polzer, K; Joosten, L; Gasser, J; Distler, J H; Ruiz, G; Baum, W; Redlich, K; Bobacz, K; Smolen, J S; van den Berg, W; Schett, G; Zwerina, J Journal: Annals of the rheumatic diseases Issue: Volume 69:Issue 01(2010) Page Start: 284 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Proteasome inhibition aggravates tumour necrosis factor-mediated bone resorption. (9th March 2010) Authors: Kireva, T; Polzer, K; Neubert, K; Meister, S; Frey, B; Baum, W; Distler, J H; Schett, G; Voll, R E; Zwerina, J Journal: Annals of the rheumatic diseases Issue: Volume 69(2010)Supplement 2 Page Start: A16 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Selective p38MAPK isoform expression and activation in antineutrophil cytoplasmatic antibody-associated crescentic glomerulonephritis: role of p38MAPKα. Issue 5 (17th August 2007) Authors: Polzer, K; Soleiman, A; Baum, W; Axmann, R; Distler, J; Redlich, K; Kilian, A; Krönke, G; Schett, G; Zwerina, J Journal: Annals of the rheumatic diseases Issue: Volume 67:Issue 5(2008) Page Start: 602 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Tumour necrosis factor blockade increases lymphangiogenesis in murine and human arthritic joints. Issue 11 (3rd January 2008) Authors: Polzer, K; Baeten, D; Soleiman, A; Distler, J; Gerlag, D M; Tak, P P; Schett, G; Zwerina, J Journal: Annals of the rheumatic diseases Issue: Volume 67:Issue 11(2008) Page Start: 1610 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗